You are here: 

Research volunteer opportunity

Community representatives are welcomed on our peer-review panels. This is a unique opportunity for volunteers and staff at all levels to participate in the evaluation of grant applications.

Participants contribute to the evaluation of applications and have considerable impact on the review process. This is an opportunity to join expert scientists as they review the best new cancer research ideas in the country, gain an appreciation of the integrity of the peer-review process as well as the value and impact of donor dollars. The role of a Community Representative is to consider cancer relevance and feasibility from a patient/caregiver/public perspective, comment on the public summary (lay language) sections for ease of understanding. Detailed scientific knowledge is not required. Community Representatives are asked to report back to their colleagues/peers through a presentation or written report. This is a valuable way of sharing the experience more broadly given the limited spaces available each year.

Community representatives must consider all applications equally regardless of their specific cancer interest. Candidates must commit time to read the applications before the meeting and be willing to attend a 1 or 2 day meeting in Toronto. Travel and accommodation will be arranged and paid for by CCS. Reasonable expenses are reimbursed. The number of applications for a panel range from 15 to 30 depending on research area and program. Reading an application may take 20-30 minutes each.

View descriptions of the panels as well as the review process.

How to get involved:

If you currently hold a volunteer and staff position with the Canadian Cancer Society, please fill out the online self-nomination form.



Dr Sean McKenna New treatments to outsmart cancer

Read more

Together we can reduce the burden of cancer

Icon - beaker

Last year, we only had the resources available to fund 40% of high-priority research projects. Imagine the impact we could have if we were able to fund 100%.

Learn more